← FDA Drug Approvals (Drugs@FDA)

RESNIBEN

NDA · New Drug Application · Sponsor: AZURITY · Approved 2025-10-24

Drug application

FDA Application #

NDA220258

Application type

New Drug Application

Brand name

RESNIBEN

Generic name

Cabozantinib

Active ingredients

CABOZANTINIB

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

AZURITY

First approval

2025-10-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown